| Product Code: ETC9474777 | Publication Date: Sep 2024 | Updated Date: Dec 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Sri Lanka import trend for oral hypoglycemic agents (OHAs) showed a growth rate of 43.03% from 2023 to 2024, with a compound annual growth rate (CAGR) of 17.08% from 2020 to 2024. This substantial increase may be attributed to rising awareness of diabetes management and improved access to healthcare services in the region.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Sri Lanka Oral Hypoglycemic Agents (OHAs) Market Overview |
3.1 Sri Lanka Country Macro Economic Indicators |
3.2 Sri Lanka Oral Hypoglycemic Agents (OHAs) Market Revenues & Volume, 2021 & 2031F |
3.3 Sri Lanka Oral Hypoglycemic Agents (OHAs) Market - Industry Life Cycle |
3.4 Sri Lanka Oral Hypoglycemic Agents (OHAs) Market - Porter's Five Forces |
3.5 Sri Lanka Oral Hypoglycemic Agents (OHAs) Market Revenues & Volume Share, By Type of Product, 2021 & 2031F |
3.6 Sri Lanka Oral Hypoglycemic Agents (OHAs) Market Revenues & Volume Share, By End Users, 2021 & 2031F |
4 Sri Lanka Oral Hypoglycemic Agents (OHAs) Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of diabetes in Sri Lanka |
4.2.2 Growing awareness about the importance of managing diabetes |
4.2.3 Technological advancements in the development of oral hypoglycemic agents (OHAs) |
4.3 Market Restraints |
4.3.1 Limited access to healthcare facilities in rural areas |
4.3.2 High cost associated with some oral hypoglycemic agents |
4.3.3 Stringent regulations and approval processes for new OHAs |
5 Sri Lanka Oral Hypoglycemic Agents (OHAs) Market Trends |
6 Sri Lanka Oral Hypoglycemic Agents (OHAs) Market, By Types |
6.1 Sri Lanka Oral Hypoglycemic Agents (OHAs) Market, By Type of Product |
6.1.1 Overview and Analysis |
6.1.2 Sri Lanka Oral Hypoglycemic Agents (OHAs) Market Revenues & Volume, By Type of Product, 2021- 2031F |
6.1.3 Sri Lanka Oral Hypoglycemic Agents (OHAs) Market Revenues & Volume, By Sulfonylureas, 2021- 2031F |
6.1.4 Sri Lanka Oral Hypoglycemic Agents (OHAs) Market Revenues & Volume, By Metformin, 2021- 2031F |
6.1.5 Sri Lanka Oral Hypoglycemic Agents (OHAs) Market Revenues & Volume, By Thiazolidinediones, 2021- 2031F |
6.1.6 Sri Lanka Oral Hypoglycemic Agents (OHAs) Market Revenues & Volume, By Alpha-Glucosidase Inhibitors, 2021- 2031F |
6.2 Sri Lanka Oral Hypoglycemic Agents (OHAs) Market, By End Users |
6.2.1 Overview and Analysis |
6.2.2 Sri Lanka Oral Hypoglycemic Agents (OHAs) Market Revenues & Volume, By Hospital, 2021- 2031F |
6.2.3 Sri Lanka Oral Hypoglycemic Agents (OHAs) Market Revenues & Volume, By Clinics, 2021- 2031F |
7 Sri Lanka Oral Hypoglycemic Agents (OHAs) Market Import-Export Trade Statistics |
7.1 Sri Lanka Oral Hypoglycemic Agents (OHAs) Market Export to Major Countries |
7.2 Sri Lanka Oral Hypoglycemic Agents (OHAs) Market Imports from Major Countries |
8 Sri Lanka Oral Hypoglycemic Agents (OHAs) Market Key Performance Indicators |
8.1 Number of diabetic patients using OHAs |
8.2 Adoption rate of newer OHAs in the market |
8.3 Patient adherence and compliance to OHA treatment regimens |
9 Sri Lanka Oral Hypoglycemic Agents (OHAs) Market - Opportunity Assessment |
9.1 Sri Lanka Oral Hypoglycemic Agents (OHAs) Market Opportunity Assessment, By Type of Product, 2021 & 2031F |
9.2 Sri Lanka Oral Hypoglycemic Agents (OHAs) Market Opportunity Assessment, By End Users, 2021 & 2031F |
10 Sri Lanka Oral Hypoglycemic Agents (OHAs) Market - Competitive Landscape |
10.1 Sri Lanka Oral Hypoglycemic Agents (OHAs) Market Revenue Share, By Companies, 2024 |
10.2 Sri Lanka Oral Hypoglycemic Agents (OHAs) Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |